| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.
|
Gastroenterology
|
2008
|
3.28
|
|
2
|
Pathobiology of ALK+ anaplastic large-cell lymphoma.
|
Blood
|
2007
|
2.65
|
|
3
|
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
|
Blood
|
2006
|
2.53
|
|
4
|
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.
|
Clin Cancer Res
|
2004
|
2.06
|
|
5
|
Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
|
Oncogene
|
2004
|
1.95
|
|
6
|
Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
|
Biochem Pharmacol
|
2005
|
1.94
|
|
7
|
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
|
Leuk Lymphoma
|
2008
|
1.91
|
|
8
|
Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways.
|
Leuk Lymphoma
|
2008
|
1.90
|
|
9
|
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.
|
Blood
|
2008
|
1.88
|
|
10
|
Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
|
Am J Pathol
|
2005
|
1.83
|
|
11
|
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.
|
Blood
|
2006
|
1.73
|
|
12
|
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
|
Clin Cancer Res
|
2009
|
1.62
|
|
13
|
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity.
|
Blood
|
2006
|
1.56
|
|
14
|
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
|
Cancer
|
2006
|
1.55
|
|
15
|
Characterization of 4 mantle cell lymphoma cell lines.
|
Arch Pathol Lab Med
|
2003
|
1.52
|
|
16
|
Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.
|
Mod Pathol
|
2006
|
1.50
|
|
17
|
Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel.
|
Mol Cancer Ther
|
2005
|
1.50
|
|
18
|
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
|
Haematologica
|
2011
|
1.48
|
|
19
|
Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.
|
Oncogene
|
2003
|
1.40
|
|
20
|
Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
|
Cancer Chemother Pharmacol
|
2008
|
1.33
|
|
21
|
Factors associated with early hospital discharge of adult influenza patients.
|
Antivir Ther
|
2007
|
1.31
|
|
22
|
Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
|
J Clin Oncol
|
2004
|
1.26
|
|
23
|
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.
|
Clin Cancer Res
|
2007
|
1.26
|
|
24
|
Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma.
|
Blood
|
2004
|
1.24
|
|
25
|
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
|
Haematologica
|
2011
|
1.24
|
|
26
|
Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.
|
Blood
|
2009
|
1.24
|
|
27
|
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
|
Blood
|
2007
|
1.23
|
|
28
|
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.
|
Blood
|
2006
|
1.22
|
|
29
|
Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.
|
J Hematol Oncol
|
2011
|
1.22
|
|
30
|
Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer.
|
Cancer Res
|
2009
|
1.21
|
|
31
|
Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.
|
Ann Surg
|
2006
|
1.20
|
|
32
|
Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.
|
J Biomed Mater Res A
|
2008
|
1.13
|
|
33
|
Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.
|
J Pathol
|
2003
|
1.12
|
|
34
|
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
|
Clin Cancer Res
|
2003
|
1.12
|
|
35
|
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
|
Am J Hematol
|
2003
|
1.10
|
|
36
|
JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells.
|
Br J Haematol
|
2006
|
1.09
|
|
37
|
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.
|
Cancer
|
2010
|
1.09
|
|
38
|
Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site.
|
Cancer Chemother Pharmacol
|
2006
|
1.09
|
|
39
|
Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
|
Am J Clin Pathol
|
2003
|
1.08
|
|
40
|
STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancer.
|
Int J Clin Exp Pathol
|
2010
|
1.07
|
|
41
|
Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
|
Clin Cancer Res
|
2003
|
1.05
|
|
42
|
Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features.
|
Am J Surg Pathol
|
2002
|
1.04
|
|
43
|
The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
|
Biomaterials
|
2009
|
1.04
|
|
44
|
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
|
Br J Haematol
|
2010
|
1.04
|
|
45
|
Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.
|
Blood
|
2007
|
1.04
|
|
46
|
Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.
|
Transl Oncol
|
2011
|
1.03
|
|
47
|
Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma.
|
Blood
|
2004
|
1.03
|
|
48
|
Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.
|
Mod Pathol
|
2002
|
1.03
|
|
49
|
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
|
J Cell Physiol
|
2010
|
1.02
|
|
50
|
NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.
|
J Signal Transduct
|
2012
|
1.02
|
|
51
|
The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.
|
Br J Haematol
|
2007
|
1.01
|
|
52
|
Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease.
|
Hum Pathol
|
2003
|
1.00
|
|
53
|
IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.
|
Am J Pathol
|
2009
|
1.00
|
|
54
|
Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.
|
Am J Pathol
|
2006
|
0.99
|
|
55
|
IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
|
Blood
|
2009
|
0.98
|
|
56
|
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
|
Am J Clin Pathol
|
2002
|
0.98
|
|
57
|
The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
|
Hum Pathol
|
2011
|
0.97
|
|
58
|
Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.
|
Immunol Cell Biol
|
2008
|
0.97
|
|
59
|
Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.
|
PLoS One
|
2013
|
0.96
|
|
60
|
Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer.
|
J Pathol
|
2012
|
0.96
|
|
61
|
Study of the anatomical variations of vertebral artery in C2 vertebra with magnetic resonance imaging and its application in the C1-C2 transarticular screw fixation.
|
Spine (Phila Pa 1976)
|
2010
|
0.96
|
|
62
|
Expansion of hematopoietic stem cells for transplantation: current perspectives.
|
Exp Hematol Oncol
|
2012
|
0.95
|
|
63
|
Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
|
Cell Signal
|
2012
|
0.95
|
|
64
|
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC).
|
Curr Cancer Drug Targets
|
2011
|
0.94
|
|
65
|
Simple and reliable determination of the modified rankin scale score in neurosurgical and neurological patients: the mRS-9Q.
|
Neurosurgery
|
2012
|
0.94
|
|
66
|
Proteome-wide identification of novel binding partners to the oncogenic fusion gene protein, NPM-ALK, using tandem affinity purification and mass spectrometry.
|
Am J Pathol
|
2009
|
0.94
|
|
67
|
β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
|
Haematologica
|
2010
|
0.93
|
|
68
|
Clinical and biological significance of GSK-3β inactivation in breast cancer-an immunohistochemical study.
|
Hum Pathol
|
2010
|
0.93
|
|
69
|
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
|
Blood
|
2004
|
0.93
|
|
70
|
Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma.
|
Mod Pathol
|
2005
|
0.93
|
|
71
|
Tumoral calcinosis: a case report.
|
J Orthop Surg (Hong Kong)
|
2011
|
0.92
|
|
72
|
Activation status of the JAK/STAT3 pathway in mantle cell lymphoma.
|
Arch Pathol Lab Med
|
2005
|
0.92
|
|
73
|
Transcriptional activation of the SALL1 by the human SIX1 homeodomain during kidney development.
|
J Biol Chem
|
2006
|
0.92
|
|
74
|
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.
|
MAbs
|
2010
|
0.91
|
|
75
|
BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
|
J Pathol
|
2003
|
0.90
|
|
76
|
Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
|
Mol Pharm
|
2010
|
0.90
|
|
77
|
miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.
|
Carcinogenesis
|
2013
|
0.88
|
|
78
|
Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma.
|
Leuk Res
|
2011
|
0.88
|
|
79
|
The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.
|
BMC Cancer
|
2014
|
0.88
|
|
80
|
Enhancing bone marrow regeneration by SALL4 protein.
|
J Hematol Oncol
|
2013
|
0.87
|
|
81
|
Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: comparison of DHPLC and DNA sequencing methods using a single population-based cohort.
|
Am J Clin Pathol
|
2010
|
0.87
|
|
82
|
Preventing healthcare workers from acquiring influenza.
|
Infect Control Hosp Epidemiol
|
2009
|
0.86
|
|
83
|
Flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia: correlation with immunocytochemistry and Western blot analysis.
|
Arch Pathol Lab Med
|
2007
|
0.86
|
|
84
|
Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma.
|
PLoS One
|
2012
|
0.86
|
|
85
|
Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells.
|
J Cell Mol Med
|
2009
|
0.86
|
|
86
|
Immunohistochemical expression of the transcription factor DP-1 and its heterodimeric partner E2F-1 in non-Hodgkin lymphoma.
|
Appl Immunohistochem Mol Morphol
|
2002
|
0.86
|
|
87
|
Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway.
|
Blood
|
2011
|
0.86
|
|
88
|
Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer.
|
Int J Clin Exp Pathol
|
2011
|
0.86
|
|
89
|
Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study.
|
Int J Clin Exp Pathol
|
2010
|
0.86
|
|
90
|
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.
|
BMC Cancer
|
2013
|
0.85
|
|
91
|
Targeted quantitative mass spectrometric identification of differentially expressed proteins between Bax-expressing and deficient colorectal carcinoma cells.
|
J Proteome Res
|
2009
|
0.85
|
|
92
|
Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma.
|
Mod Pathol
|
2006
|
0.85
|
|
93
|
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
|
J Clin Oncol
|
2013
|
0.85
|
|
94
|
Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.
|
PLoS One
|
2013
|
0.85
|
|
95
|
Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma.
|
Am J Pathol
|
2004
|
0.85
|
|
96
|
NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.
|
Int J Clin Exp Pathol
|
2011
|
0.84
|
|
97
|
Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets.
|
Am J Clin Pathol
|
2002
|
0.84
|
|
98
|
The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
|
Carcinogenesis
|
2007
|
0.84
|
|
99
|
A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility.
|
Eur J Hum Genet
|
2012
|
0.84
|
|
100
|
Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma.
|
Cell Signal
|
2011
|
0.84
|
|
101
|
Community case of methicillin-resistant Staphylococcus aureus infection.
|
Emerg Infect Dis
|
2006
|
0.84
|
|
102
|
Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors.
|
Am J Pathol
|
2002
|
0.84
|
|
103
|
Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
|
Int J Pharm
|
2007
|
0.83
|
|
104
|
Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
|
Mol Pharm
|
2014
|
0.83
|
|
105
|
Functional characterization of the kinase activation loop in nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) using tandem affinity purification and liquid chromatography-mass spectrometry.
|
J Biol Chem
|
2009
|
0.82
|
|
106
|
Caspase-3 activation in systemic anaplastic large-cell lymphoma.
|
Mod Pathol
|
2004
|
0.81
|
|
107
|
Chronic lymphocytic leukemia with t(14;18) and trisomy 12.
|
Arch Pathol Lab Med
|
2002
|
0.80
|
|
108
|
Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
|
J Biomed Mater Res A
|
2013
|
0.80
|
|
109
|
Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma.
|
Mol Cell Proteomics
|
2010
|
0.80
|
|
110
|
Gene methylation and silencing of SOCS3 in mantle cell lymphoma.
|
Br J Haematol
|
2013
|
0.80
|
|
111
|
Differential expression of WT1 gene product in non-Hodgkin lymphomas.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.80
|
|
112
|
A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer.
|
J Pathol
|
2012
|
0.80
|
|
113
|
Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential.
|
Carcinogenesis
|
2010
|
0.79
|
|
114
|
Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphoma.
|
Lab Invest
|
2006
|
0.79
|
|
115
|
The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.
|
J Biol Chem
|
2010
|
0.78
|
|
116
|
Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.
|
Mod Pathol
|
2005
|
0.78
|
|
117
|
Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm.
|
PLoS One
|
2013
|
0.78
|
|
118
|
The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma.
|
Cell Signal
|
2012
|
0.78
|
|
119
|
Genetic screening for synthetic lethal partners of polynucleotide kinase/phosphatase: potential for targeting SHP-1-depleted cancers.
|
Cancer Res
|
2012
|
0.78
|
|
120
|
Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma.
|
Cell Signal
|
2012
|
0.78
|
|
121
|
Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein.
|
Am J Pathol
|
2011
|
0.78
|
|
122
|
Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
|
Mod Pathol
|
2008
|
0.78
|
|
123
|
Transmission of a follicular lymphoma by allogeneic bone marrow transplantation--evidence to support the existence of lymphoma progenitor cells.
|
Br J Haematol
|
2006
|
0.77
|
|
124
|
CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype.
|
Arch Pathol Lab Med
|
2003
|
0.77
|
|
125
|
Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
|
Arch Pathol Lab Med
|
2003
|
0.77
|
|
126
|
The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.
|
BMC Cancer
|
2012
|
0.77
|
|
127
|
Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics.
|
Leuk Lymphoma
|
2011
|
0.76
|
|
128
|
siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.
|
Pharm Res
|
2011
|
0.76
|
|
129
|
Quantitative proteomic analysis of HER2 normal and overexpressing MCF-7 breast cancer cells revealed proteomic changes accompanied with HER2 gene amplification.
|
J Proteomics
|
2013
|
0.76
|
|
130
|
Acute lymphoblastic leukemia in elderly patients the Philadelphia chromosome may not be a significant adverse prognostic factor.
|
Am J Clin Pathol
|
2002
|
0.76
|
|
131
|
Hypervirulent Clone of Group B Streptococcus Serotype III Sequence Type 283, Hong Kong, 1993-2012.
|
Emerg Infect Dis
|
2016
|
0.75
|
|
132
|
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach.
|
Pancreas
|
2016
|
0.75
|
|
133
|
Unexpected immunohistochemical localization of deoxycytidine kinase.
|
Clin Cancer Res
|
2006
|
0.75
|
|
134
|
Re: Rust et al. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol 2005;206:445-450.
|
J Pathol
|
2005
|
0.75
|
|
135
|
A definitive diagnosis of primary Hodgkin lymphoma on endoscopic biopsy material utilizing in-depth immunohistochemical analysis.
|
Can J Gastroenterol
|
2007
|
0.75
|
|
136
|
Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease.
|
Pediatr Infect Dis J
|
2005
|
0.75
|
|
137
|
Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum.
|
Leuk Lymphoma
|
2002
|
0.75
|
|
138
|
Identification of a novel crosstalk between casein kinase 2α and NPM-ALK in ALK-positive anaplastic large cell lymphoma.
|
Cell Signal
|
2012
|
0.75
|
|
139
|
Cyclin D1 and t(11;14)-positive B-cell neoplasms resembling marginal zone B-cell lymphoma: a morphological variant of mantle cell lymphoma.
|
Hum Pathol
|
2007
|
0.75
|
|
140
|
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.
|
Leuk Lymphoma
|
2008
|
0.75
|